JNJ Jan 2025 120.000 put
| Previous Close | 2.8600 |
| Open | 2.5500 |
| Bid | 2.3800 |
| Ask | 2.8700 |
| Strike | 120.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 2.5500 - 2.8000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 1.23k |
- Motley Fool
2 Reasons to Buy Johnson & Johnson, and 2 Reasons to Sell
There are plenty of reasons why many investors enjoy holding shares in Johnson & Johnson (NYSE: JNJ), one of the world's largest healthcare businesses. With the company's impressive track record of dividend payments and its pipeline's massive throughput of new medicines, it's clear that this stock will be around for the foreseeable future. Johnson & Johnson's product mix makes it worth buying in times like now when inflation is higher than average.
- Motley Fool
1 Resilient Blue Chip Stock to Buy on the Dip
Johnson & Johnson is facing issues that are causing investors to look elsewhere (more on those below). Let's look into why opportunistic investors should seriously consider buying shares of Johnson & Johnson as they sink. On Jan. 24, Johnson & Johnson released its fourth-quarter and full-year 2022 financial results.
- Motley Fool
2 Stocks Down More Than 6% to Buy Right Now
In fact, two stocks that outperformed the S&P 500 last year are now down more than 6% since the start of the year: Johnson & Johnson (NYSE: JNJ) and AbbVie (NYSE: ABBV).. Motley Fool contributors Adria Cimino and Keith Speights talk about why these two stocks actually make great buys right now. Adria Cimino (Johnson & Johnson): J&J may have disappointed investors when it reported fourth-quarter earnings on Jan. 24.
